Yakimov Alexander, Pobegalov Georgii, Bakhlanova Irina, Khodorkovskii Mikhail, Petukhov Michael, Baitin Dmitry
Department of Molecular and Radiation Biophysics, Petersburg Nuclear Physics Institute (B.P.Konstantinov of National Research Centre 'Kurchatov Institute'), Gatchina 188300, Russia.
Peter the Great St Petersburg Polytechnic University, St Petersburg 195251, Russia.
Nucleic Acids Res. 2017 Sep 19;45(16):9788-9796. doi: 10.1093/nar/gkx687.
The RecX protein, a very active natural RecA protein inhibitor, can completely disassemble RecA filaments at nanomolar concentrations that are two to three orders of magnitude lower than that of RecA protein. Based on the structure of RecX protein complex with the presynaptic RecA filament, we designed a short first in class α-helical peptide that both inhibits RecA protein activities in vitro and blocks the bacterial SOS-response in vivo. The peptide was designed using SEQOPT, a novel method for global sequence optimization of protein α-helices. SEQOPT produces artificial peptide sequences containing only 20 natural amino acids with the maximum possible conformational stability at a given pH, ionic strength, temperature, peptide solubility. It also accounts for restrictions due to known amino acid residues involved in stabilization of protein complexes under consideration. The results indicate that a few key intermolecular interactions inside the RecA protein presynaptic complex are enough to reproduce the main features of the RecX protein mechanism of action. Since the SOS-response provides a major mechanism of bacterial adaptation to antibiotics, these results open new ways for the development of antibiotic co-therapy that would not cause bacterial resistance.
RecX蛋白是一种非常活跃的天然RecA蛋白抑制剂,它能在纳摩尔浓度下完全拆解RecA丝,该浓度比RecA蛋白低两到三个数量级。基于RecX蛋白与突触前RecA丝的复合物结构,我们设计了一种首个此类α-螺旋短肽,它既能在体外抑制RecA蛋白活性,又能在体内阻断细菌的SOS反应。该肽是使用SEQOPT设计的,这是一种用于蛋白质α-螺旋全局序列优化的新方法。SEQOPT产生仅包含20种天然氨基酸的人工肽序列,在给定的pH、离子强度、温度和肽溶解度下具有最大可能的构象稳定性。它还考虑了由于参与所研究蛋白质复合物稳定的已知氨基酸残基所导致的限制。结果表明,RecA蛋白突触前复合物内部的一些关键分子间相互作用足以重现RecX蛋白作用机制的主要特征。由于SOS反应是细菌对抗生素产生适应性的主要机制,这些结果为开发不会导致细菌耐药性的抗生素联合疗法开辟了新途径。